Specify a stock or a cryptocurrency in the search bar to get a summary
4BASEBIO UK SOCIETAS
4BB4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company offers AVV and Lentivirus manufacturing services for use in gene therapies and vaccines. It also offers access to its targeted non-viral delivery platform, Hermes. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom. Address: 25 Norman Way, Cambridge, United Kingdom, CB24 5QE
Analytics
WallStreet Target Price
135 562.86 GBXP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 4BB
Dividend Analytics 4BB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 4BB
Stock Valuation 4BB
Financials 4BB
Results | 2019 | Dynamics |